Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Study: Antidepressants Do Not Increase Autism Risk

By R&D Editors | November 22, 2013

(Source: Kit4na/Flickr)New research cannot establish a close connection between the use of antidepressant medication-the so-called SSRIs-during the course of pregnancy and the risk of having a child with autism. The study was published in the journal Clinical Epidemiology.
 
“More and more women are given antidepressant medication while they are pregnant. And an increasing number of children are diagnosed with autism. This has given rise to concern over a possible connection,” says Jakob Christensen, researcher at Aarhus University and staff specialist at Aarhus University Hospital. “In contrast to other, smaller studies, our survey cannot demonstrate that the risk of having a child with autism is increased by taking antidepressant medication during pregnancy,” 
 
Previous research has shown that the risk of having a child with autism is up to five times greater for pregnant women who take antidepressant medication.
 
In a large register study, Christensen and colleagues at Aarhus University and Aarhus University Hospital have followed more than 600,000 Danish children born in the period between 1996 to 2006. The survey is the largest so far undertaken of the correlation between antidepressant medication during pregnancy and autism.
 
The initial results of the Danish study showed that there was almost a 2% risk of having a child with autism for pregnant women who take antidepressant medication during their pregnancy. For women who do not take antidepressant medication during pregnancy the risk was 1.5%. But the researchers also analyzed siblings and parents’ psychiatric diagnoses. And when these are taken into account the risk is shown to be minimal.
 
“We know from previous studies that there is an increased risk for autism, among other things, if the parents have a mental diagnosis such as depression. But we cannot demonstrate that the risk is further increased if the mother has received prescription antidepressant medication during the pregnancy,” says Jakob Christensen. “By analyzing data for siblings we can see that the risk of having a child with autism is largely the same regardless of whether the mother takes antidepressant medication or not during the pregnancy.”
 
The researchers cannot thereby demonstrate that the medication is to blame for autism in children.
 
Many women have antidepressant drugs prescribed by their general practitioner. Researcher in general practice Mogens Vestergaard believes that the survey also contains important knowledge for general practitioners. 
 
“Most of the people who receive SSRIs get them through their general practitioner. This was also the case for 80% of the women who received antidepressant medication in the study,” says Professor Mogens Vestergaard from Aarhus University. “Of course the results of the survey provide important knowledge for the general practitioners. They are the ones who meet pregnant women who are nervous about the consequences of taking antidepressant medication during their pregnancy.”
 
The researchers stress that there may be other risks associated with taking antidepressant medication during pregnancy. People should therefore contact their medical doctor in any case if they are under medication and considering becoming pregnant, so that they can receive the best possible advice.
 
 
Date: November 22, 2013
Source: Aarhus University 

Related Articles Read More >

Festo pumps 8% of revenue into R&D, driving miniaturized automation for life sciences
New NVIDIA AI achieves over 75% ‘co-designability’ in atom-level protein generation, doubling the success rate of prior methods
AI system found over 300 potential antibiotic compounds in snake and spider venom
5 R&D developments to keep an eye on this week: Solar crash and Trump’s energy pivot meets Musk’s rebellion
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE